Literature DB >> 1679278

Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study.

D N Louis1, S Edgerton, A D Thor, E T Hedley-Whyte.   

Abstract

Proliferating cell nuclear antigen (PCNA) is a 36-kDa DNA polymerase-delta auxiliary protein which accumulates in the nucleus during S phase of the cell cycle. Immunohistochemical labeling indices (LI) of PCNA and Ki-67 were compared using an avidin-biotin complex method on frozen sections of 27 nervous system tumors. 3 normal cerebral cortices, and 3 peripheral nerves. In glial tumors, PCNA and Ki-67 LI increased with increasing tumor grade (Daumas-Duport system). In 5 low-grade glial tumors, PCNA and Ki-67 LI were less than or equal to 1%, except for one optic nerve glioma (Ki-67 LI = 6%). In 7 grade 3 astrocytomas and 1 mixed glioma, PCNA LI were less than or equal to 1-1.5%, while Ki-67 LI were 2%-10%. In 7 grade 4 astrocytomas and 1 metastatic carcinoma, PCNA LI ranged from 6%-15% while Ki-67 LI ranged from 17%-30%. In 5 of 6 schwannomas, focally high PCNA LI (4%-65%) were noted, despite low LI with Ki-67 (less than or equal to 1.6%). Scattered normal schwann cell nuclei also stained with PCNA, but normal cerebral cortex did not.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679278     DOI: 10.1007/bf00296379

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

1.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.

Authors:  P Galand; C Degraef
Journal:  Cell Tissue Kinet       Date:  1989-09

3.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

4.  Demonstration of proliferating cell nuclear antigen (PCNA/cyclin) in glioma cells.

Authors:  K Tabuchi; C Honda; P K Nakane
Journal:  Neurol Med Chir (Tokyo)       Date:  1987-01       Impact factor: 1.742

5.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

6.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

8.  Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

Authors:  B A Robbins; D de la Vega; K Ogata; E M Tan; R M Nakamura
Journal:  Arch Pathol Lab Med       Date:  1987-09       Impact factor: 5.534

9.  The use of the monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors.

Authors:  T Shibata; P C Burger
Journal:  Childs Nerv Syst       Date:  1987       Impact factor: 1.475

10.  Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.

Authors:  K Ogata; P Kurki; J E Celis; R M Nakamura; E M Tan
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

View more
  33 in total

1.  Comparison of Ki-67 equivalent antibodies.

Authors:  C F Lindboe; S H Torp
Journal:  J Clin Pathol       Date:  2002-06       Impact factor: 3.411

2.  Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.

Authors:  Karl Roessler; Alexander Bertalanffy; Hussun Jezan; Achmed Ba-Ssalamah; Irene Slavc; Thomas Czech; Herbert Budka
Journal:  J Neurooncol       Date:  2002-06       Impact factor: 4.130

3.  PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Derya Gümürdühü; Handan Zeren; Tahsin Erman
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

4.  Enhanced apoptosis in pilocytic astrocytoma: a comparative study of apoptosis and proliferation in astrocytic tumors.

Authors:  Akira Nakamizo; Takanori Inamura; Kiyonobu Ikezaki; Koji Yoshimoto; Satoshi Inoha; Masahiro Mizoguchi; Toshiyuki Amano; Masashi Fukui
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

Review 5.  Techniques to assess the proliferative potential of brain tumors.

Authors:  Alfredo Quiñones-Hinojosa; Nader Sanai; Justin S Smith; Michael W McDermott
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

6.  Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.

Authors:  E Karamitopoulou; E Perentes; M Melachrinou; T Maraziotis
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  The expression of survivin and Ki-67 in meningiomas: correlation with grade and clinical outcome.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Nebil Bal; Bulent Erdogan; Seyda Erdogan; Tahsin Erman
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

8.  Different dose-dependent effects of ebselen in sciatic nerve ischemia-reperfusion injury in rats.

Authors:  Filiz Ozyigit; Aysegul Kucuk; Sezer Akcer; Murat Tosun; Fatma Emel Kocak; Cengiz Kocak; Ahmet Kocak; Hasan Metineren; Osman Genc
Journal:  Bosn J Basic Med Sci       Date:  2015-08-26       Impact factor: 3.363

9.  p53 protein expression in central nervous system neoplasms.

Authors:  M Barbareschi; P Iuzzolino; A Pennella; A Allegranza; G Arrigoni; P Dalla Palma; C Doglioni
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

10.  PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.

Authors:  E Leonardi; S Girlando; G Serio; F A Mauri; G Perrone; S Scampini; P Dalla Palma; M Barbareschi
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.